Skip to main content

Advertisement

Log in

Well-known polypeptides of deer antler velvet with key actives: modern pharmacological advances

  • Review
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Deer antler velvet, with kidney tonifying, promoting the production of essence and blood, strengthening tendons and bones, not only has a thousand-year medicinal history but also its modern pharmacology mainly focuses on its active polypeptides on motor, nerve, and immune systems. The purpose of this report is to fill the gap in the comprehensive, systematic, and detailed review of polypeptides during the recent 30 years (1992–2023). The research method was to review 53 pharmacological articles from the Public Medicine, Web of science, ACS, and Science Direct database sources by searching the keywords “pilose antler,” “deer velvet,” “Pilose Antler Peptide (PAP) and Velvet Antler Polypeptide (VAP).” The results showed that deer antler polypeptides (DAPs), by regulating EGF, EGFR, MAPK, P38, ERK, NF-κB, Wnt, PI3K, Akt, MMP, AMPK, Stir1, NLRP3, HO-1, Nrf, Rho, TLR, TGF-β, Smad, Ang II, etc., revealed their effects on seven system-related diseases and their mechanisms, including osteoarthritis, intervertebral disc degeneration, osteoporosis, Alzheimer’s, Parkinson’s, triple-negative breast cancer, liver injury, liver fibrosis, cardiovascular disease, acute lung injury, and late-onset hypogonadism. In conclusion, DAPs have good effects on motor and other system-related diseases, but the secondary and tertiary structures of DAPs (0.5–1800 KDa) need to be further elucidated, and the structure–activity relationship study is still unavailable and needs to be covered. It is expected that this review may provide the necessary literature support for further research.

Graphical Abstract

The activities and mechanisms of polypeptides from the past 30 years (1992–2023) are summarized covering seven systems, related diseases, and its regulatory genes and proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

Not applicable.

References

Download references

Funding

This work was supported by the Department of Science and Technology, Jilin Province, China (grant number YDZJ202201ZYTS249).

Author information

Authors and Affiliations

Authors

Contributions

He Sun: overall instructor; Dandan Xiao, Wei Liu, and Xue Li: resources and data collection; Zhe Lin and Yong Li: some constructive suggestions put forward for revising the article. Yuling Ding: final correction, editing, and approval. All authors have read and approved this paper for publication. The authors confirm that no paper mill and artificial intelligence was used.

Corresponding authors

Correspondence to Yong Li or Yuling Ding.

Ethics declarations

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, H., Xiao, D., Liu, W. et al. Well-known polypeptides of deer antler velvet with key actives: modern pharmacological advances. Naunyn-Schmiedeberg's Arch Pharmacol 397, 15–31 (2024). https://doi.org/10.1007/s00210-023-02642-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-023-02642-y

Keywords

Navigation